Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1055

1.

Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with post-infectious, Borrelia burgdorferi-induced Lyme arthritis.

Lochhead RB, Arvikar SL, Aversa JM, Sadreyev RI, Strle K, Steere AC.

Cell Microbiol. 2018 Sep 14:e12954. doi: 10.1111/cmi.12954. [Epub ahead of print]

PMID:
30218476
2.

Serological diagnostics of Lyme borreliosis: comparison of universal and Borrelia species-specific tests based on whole-cell and recombinant antigens.

Kodym P, Kurzová Z, Berenová D, Pícha D, Smíšková D, Moravcová L, Malý M.

J Clin Microbiol. 2018 Sep 5. pii: JCM.00601-18. doi: 10.1128/JCM.00601-18. [Epub ahead of print]

3.

Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution.

Jarosz AC, Badawi A.

Inflamm Res. 2018 Aug 18. doi: 10.1007/s00011-018-1180-5. [Epub ahead of print] Review.

PMID:
30121835
4.

Plasma lipidomic profile signature of rheumatoid arthritis versus Lyme arthritis patients.

Łuczaj W, Moniuszko-Malinowska A, Domingues P, Domingues MR, Gindzienska-Sieskiewicz E, Skrzydlewska E.

Arch Biochem Biophys. 2018 Sep 15;654:105-114. doi: 10.1016/j.abb.2018.07.021. Epub 2018 Jul 27.

PMID:
30059653
5.

MRP8/14 does not contribute to dissemination or inflammation in a murine model of Lyme borreliosis.

Mason LMK, Coumou J, Ersöz JI, Oei A, Roelofs JJTH, Vogl T, van der Poll T, Hovius JWR.

Immunobiology. 2018 Nov;223(11):694-698. doi: 10.1016/j.imbio.2018.07.017. Epub 2018 Jul 17.

PMID:
30056999
6.

The Emergence of a Forgotten Entity: Dermatomyositis-like Presentation of Lyme Disease in Rural Wisconsin.

Novitch M, Wahab A, Kakarala R, Mukerji R.

Cureus. 2018 May 10;10(5):e2608. doi: 10.7759/cureus.2608.

7.

Borreliosis in Sport Horse Practice.

Swinebroad EL.

Vet Clin North Am Equine Pract. 2018 Aug;34(2):313-343. doi: 10.1016/j.cveq.2018.04.011. Review.

PMID:
30007449
8.

An Immunosuppressive Tick Salivary Gland Protein DsCystatin Interferes With Toll-Like Receptor Signaling by Downregulating TRAF6.

Sun T, Wang F, Pan W, Wu Q, Wang J, Dai J.

Front Immunol. 2018 Jun 1;9:1245. doi: 10.3389/fimmu.2018.01245. eCollection 2018.

9.

Lyme periprosthetic joint infection in total knee arthroplasty.

Adrados M, Wiznia DH, Golden M, Pelker R.

Arthroplast Today. 2018 Jan 19;4(2):158-161. doi: 10.1016/j.artd.2017.12.003. eCollection 2018 Jun.

10.

Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014.

Johnson KO, Nelder MP, Russell C, Li Y, Badiani T, Sander B, Sider D, Patel SN.

PLoS One. 2018 Jun 1;13(6):e0198509. doi: 10.1371/journal.pone.0198509. eCollection 2018.

11.

Correlation of Lyme Disease-Associated IgG4 Autoantibodies With Synovial Pathology in Antibiotic-Refractory Lyme Arthritis.

Sulka KB, Strle K, Crowley JT, Lochhead RB, Anthony R, Steere AC.

Arthritis Rheumatol. 2018 May 23. doi: 10.1002/art.40566. [Epub ahead of print]

PMID:
29790305
12.

Sternoclavicular Arthritis as a Clinical Presentation for Lyme Disease.

Ramgopal S, Rosenkranz M, Nowalk AJ, Zuckerbraun NS.

Pediatrics. 2018 Apr;141(Suppl 5):S466-S469. doi: 10.1542/peds.2017-0725.

PMID:
29610173
13.

Tick borne illness-Lyme disease.

Bush LM, Vazquez-Pertejo MT.

Dis Mon. 2018 May;64(5):195-212. doi: 10.1016/j.disamonth.2018.01.007. Review.

PMID:
29402399
14.

IL-10 Deficiency Reveals a Role for TLR2-Dependent Bystander Activation of T Cells in Lyme Arthritis.

Whiteside SK, Snook JP, Ma Y, Sonderegger FL, Fisher C, Petersen C, Zachary JF, Round JL, Williams MA, Weis JJ.

J Immunol. 2018 Feb 15;200(4):1457-1470. doi: 10.4049/jimmunol.1701248. Epub 2018 Jan 12.

PMID:
29330323
15.

Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling.

Sahay B, Bashant K, Nelson NLJ, Patsey RL, Gadila SK, Boohaker R, Verma A, Strle K, Sellati TJ.

Infect Immun. 2018 Mar 22;86(4). pii: e00781-17. doi: 10.1128/IAI.00781-17. Print 2018 Apr.

16.

Isoforskolin downregulates proinflammatory responses induced by Borrelia burgdorferi basic membrane protein A.

Zhao H, Liu A, Shen L, Xu C, Zhu Z, Yang J, Han X, Bao F, Yang W.

Exp Ther Med. 2017 Dec;14(6):5974-5980. doi: 10.3892/etm.2017.5300. Epub 2017 Oct 13.

17.

Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.

Siitonen R, Pietikäinen A, Liljenbäck H, Käkelä M, Söderström M, Jalkanen S, Hytönen J, Roivainen A.

Arthritis Res Ther. 2017 Nov 22;19(1):254. doi: 10.1186/s13075-017-1460-4.

18.

Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.

Lin YP, Li L, Zhang F, Linhardt RJ.

Microbiology. 2017 Dec;163(12):1759-1766. doi: 10.1099/mic.0.000571. Epub 2017 Nov 8.

19.

[History of the study, epidemiology of the disease and characterization of Borrelia burgdorferi infection].

Płusa T.

Pol Merkur Lekarski. 2017 Sep 29;43(255):99-103. Polish.

PMID:
28987040
20.

Genetic Control of Lyme Arthritis by Borrelia burgdorferi Arthritis-Associated Locus 1 Is Dependent on Localized Differential Production of IFN-β and Requires Upregulation of Myostatin.

Paquette JK, Ma Y, Fisher C, Li J, Lee SB, Zachary JF, Kim YS, Teuscher C, Weis JJ.

J Immunol. 2017 Nov 15;199(10):3525-3534. doi: 10.4049/jimmunol.1701011. Epub 2017 Oct 6.

PMID:
28986440

Supplemental Content

Loading ...
Support Center